Katherine M Flegal1, Orestis A Panagiotou2, Barry I Graubard2. 1. Centers for Disease Control and Prevention, National Center for Health Statistics, Hyattsville, MD. Electronic address: kmf2@cdc.gov. 2. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Abstract
PURPOSE: Obesity is a highly prevalent condition in the United States and elsewhere and is associated with increased mortality and morbidity. Here, we discuss some issues involved in quantifying the health burden of obesity using population attributable fraction (PAF) estimates and provide examples. METHODS: We searched PubMed for articles reporting attributable fraction estimates for obesity. We reviewed eligible articles to identify methodological concerns and tabulated illustrative examples of PAF estimates for obesity relative to cancer, diabetes, cardiovascular disease, and all-cause mortality. RESULTS: There is considerable variability among studies regarding the methods used for PAF calculation and the selection of appropriate counterfactuals. The reported estimates ranged from 5% to 15% for all-cause mortality, -0.2% to 8% for all-cancer incidence, 7% to 44% for cardiovascular disease incidence, and 3% to 83% for diabetes incidence. CONCLUSIONS: To evaluate a given estimate, it is important to consider whether the exposure and outcome were defined similarly for the PAF and for the relative risks, whether the relative risks were suitable for the population at hand, and whether PAF was calculated using correct methods. Strong causal assumptions are not necessarily warranted. In general, PAFs for obesity may be best considered as indicators of association. Published by Elsevier Inc.
PURPOSE:Obesity is a highly prevalent condition in the United States and elsewhere and is associated with increased mortality and morbidity. Here, we discuss some issues involved in quantifying the health burden of obesity using population attributable fraction (PAF) estimates and provide examples. METHODS: We searched PubMed for articles reporting attributable fraction estimates for obesity. We reviewed eligible articles to identify methodological concerns and tabulated illustrative examples of PAF estimates for obesity relative to cancer, diabetes, cardiovascular disease, and all-cause mortality. RESULTS: There is considerable variability among studies regarding the methods used for PAF calculation and the selection of appropriate counterfactuals. The reported estimates ranged from 5% to 15% for all-cause mortality, -0.2% to 8% for all-cancer incidence, 7% to 44% for cardiovascular disease incidence, and 3% to 83% for diabetes incidence. CONCLUSIONS: To evaluate a given estimate, it is important to consider whether the exposure and outcome were defined similarly for the PAF and for the relative risks, whether the relative risks were suitable for the population at hand, and whether PAF was calculated using correct methods. Strong causal assumptions are not necessarily warranted. In general, PAFs for obesity may be best considered as indicators of association. Published by Elsevier Inc.
Entities:
Keywords:
Body mass index; Body weight; Epidemiologic methods; Obesity; Risk
Authors: Katherine M Flegal; Barry I Graubard; David F Williamson; Mitchell H Gail Journal: J Womens Health (Larchmt) Date: 2007-11 Impact factor: 2.681
Authors: E L de Hollander; M Van Zutphen; R P Bogers; W J E Bemelmans; L C P G M De Groot Journal: J Nutr Health Aging Date: 2012-01 Impact factor: 4.075
Authors: Eleonora Dal Grande; Tiffany Gill; Lydia Wyatt; Catherine R Chittleborough; Patrick J Phillips; Anne W Taylor Journal: Obes Res Clin Pract Date: 2009-08 Impact factor: 2.288
Authors: Katherine M Flegal; John A Shepherd; Anne C Looker; Barry I Graubard; Lori G Borrud; Cynthia L Ogden; Tamara B Harris; James E Everhart; Nathaniel Schenker Journal: Am J Clin Nutr Date: 2008-12-30 Impact factor: 7.045
Authors: Jan P Vandenbroucke; Erik von Elm; Douglas G Altman; Peter C Gøtzsche; Cynthia D Mulrow; Stuart J Pocock; Charles Poole; James J Schlesselman; Matthias Egger Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: Johannes Hebebrand; Jens-Christian Holm; Euan Woodward; Jennifer Lyn Baker; Ellen Blaak; Dominique Durrer Schutz; Nathalie J Farpour-Lambert; Gema Frühbeck; Jason G C Halford; Lauren Lissner; Dragan Micic; Dana Mullerova; Gabriela Roman; Karin Schindler; Hermann Toplak; Tommy L S Visscher; Volkan Yumuk Journal: Obes Facts Date: 2017-07-22 Impact factor: 3.942
Authors: Andrea Ruiz-Alejos; Rodrigo M Carrillo-Larco; J Jaime Miranda; Robert H Gilman; Liam Smeeth; Antonio Bernabé-Ortiz Journal: Public Health Nutr Date: 2019-06-04 Impact factor: 4.022
Authors: Bradley M Appelhans; Simone A French; Tamara Olinger; Michael Bogucki; Imke Janssen; Elizabeth F Avery-Mamer; Lisa M Powell Journal: Appetite Date: 2018-03-15 Impact factor: 3.868
Authors: Geoff B Dougherty; Sherita H Golden; Alden L Gross; Elizabeth Colantuoni; Lorraine T Dean Journal: Am J Prev Med Date: 2020-08-27 Impact factor: 5.043
Authors: David T Liss; Emily A Finch; Dyanna L Gregory; Andrew Cooper; Ronald T Ackermann Journal: Contemp Clin Trials Date: 2015-12-02 Impact factor: 2.226